Login General Information
Archives Company Information
Logout Forgot Password?  
Transmittal Form  
 
   
Home JAGNotes - Morning JAGNotes - Intraday Rumor Room
 
  Archived JAGNotes For Monday, January 22, 2018
Sort By Time     Sort By Firm     Sort By Symbol    

  Previous Page   1   2   3   4   5   6   7   Next Page  

Notes Posted On -- Monday January 22,2018

1)  07:38 am ET  Economic Calendar
Monday:
December National Activity Index
Tuesday:
Richmond Fed Manufacturing Index
Wednesday:
Existing Home Sales
Thursday:
New Home Sales
Kansas City Manufacturing Index
Friday:
First Quarter GDP Estimates
2)  07:39 am ET  Market Futures
U.S. Stock Futures
S&P +0.50 / +0.02%

Nasdaq +3.50 / +0.05%

Dow -33.00 / -0.13%

Data as of 8:28am ET
3)  07:39 am ET  Pre-Market Movers S&P
What`s Moving Pre-Market
S&P 500 Gainers & Losers Price Pre-Market % Change Volume
HAL Halliburton Co 54.45 +2.72% 95,542
XRX Xerox Corp 32.66 +2.70% 850
WYNN Wynn Resorts Ltd 183.50 +2.15% 15,602
IRM Iron Mountain Inc 36.25 +2.14% 135
HOG Harley-Davidson Inc 54.10 +2.08% 1,010
LLY Eli Lilly and Co 83.50 -2.33% 2,399
SYMC Symantec Corp 26.93 -1.93% 1,703
AIG American Internation... 60.51 -1.69% 5,844
CRM Salesforce.com Inc 110.43 -1.34% 379
WFC Wells Fargo & Co 63.41 -1.26% 17,759
Data as of 8:22am ET
4)  07:41 am ET  The Wall Street Journal
Activist Allies Push Xerox on Sale- Two large Xerox investors, billionaires Carl Icahn and
Darwin Deason, have formed an alliance and plan to encourage the printer and copier giant to
explore a potential sale.

Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion- Sanofi said it would buy
hemophilia drugmaker Bioverativ for more than $11.5 billion, as the French drugmaker looks to
clinch a big deal while it braces for generic competition for its top-selling product.

Frackers Could Make Real Money in 2018, If They Don't Blow It- Shale producers say drilling
plans for 2018 remain modest despite recently surging crude prices-a break with the industry's
cycle of aggressive drilling when prices are high, creating an oversupply that pushes prices
back down.

China Races Ahead in Gene Editing- U.S. scientists helped devise the Crispr biotechnology tool
that has captured global attention for its potential to treat incurable diseases. The first to
test it in humans are Chinese doctors, who don't face the same regulatory hurdles as American
counterparts.

What Facebook's Feed Changes Mean for the News- Publishers would be wise to reduce their
dependency on Facebook as it gets ready to tweak its algorithm.
5)  07:44 am ET  Credit Suisse First Boston Corp.
(CSTE)  Downgrade  The firm lowered shares from Neutral to Underperform with a price target of $21. CaesarStone Sdot-Yam closed at $23.70 
6)  07:45 am ET  CIBC World Markets Corp.
(FCX)  Downgrade  The firm lowered shares from Outperformer to Neutral with a price target of $22. Freeport-McMoRan closed at $19.96 
7)  07:45 am ET  Raymond James & Associates Inc.
(MKTX)  Downgrade  The firm lowered shares from Outperform to Market Perform. MarketAxess closed at $208.39 
8)  07:46 am ET  RBC Capital Markets
(PII)  Downgrade  The firm lowered shares from Outperform to Sector Perform with a price target of $127. Polaris Industries closed at $134.70 
9)  07:47 am ET  Citigroup
(ESPR)  Downgrade  The firm lowered shares from Buy to Neutral with a price target of $96. Esperion Therapeutics closed at $77.20 
(IPAR)  Downgrade  The firm lowered shares from Buy to Neutral with a price target of $52. Inter Parfums closed at $47.80 
10)  07:48 am ET  Baird
(CAFD)  Downgrade  The firm lowered shares from Outperform to Neutral with a price target of $26. 8point3 Energy Partners LP closed at $15.02 

  Previous Page   1   2   3   4   5   6   7   Next Page  

JagNotes.com 2018 JAG Media LLC. All rights reserved.
Research is obtained from sources believed to be reliable. However, JAG Media cannot attest to the completeness or accuracy of information. JAG Media is in no way affiliated with such firms and assumes no responsibility for the recommendations provided. Questions regarding recommendations should be directed to the appropriate firm.